Eventide Asset Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
2019
Q1
$7.25M Buy
2018
Q4
$942K Hold
2018
Q3
$4.53M Hold
2018
Q2
$4.8M Hold
2018
Q1
$6.16M Hold
2017
Q4
$8.36M Buy
2017
Q3
$25K Buy
2014
Q4
Sell
2014
Q3
$655K Hold
2014
Q2
$599K Hold
2014
Q1
$607K Hold
2013
Q4
$435K Buy